ASTC ASTROTECH Corp
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1001907 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-29.5%
TTM net income YoY0.9%
TTM EPS YoY—
Revenue 3-yr CAGR-7.8%
Net income 3-yr CAGR—
Margins
Gross margin14.8%
Operating margin-1,531.0%
Net margin-1,561.1%
FCF margin-1,477.9%
EBITDA margin-1,433.7%
Returns
ROE-84.3%
ROA-67.8%
ROIC (approx.)-78.7%
Asset turnover0.04x
Leverage & solvency
Liabilities / assets21.7%
Debt / equity0.00x
Current ratio7.24x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.91x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue51.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $913,000 | $1.05M |
| Cost of revenue | $696,000 | $574,000 |
| Gross profit | $217,000 | $475,000 |
| R&D expense | $6.48M | $8.14M |
| SG&A expense | $7.87M | $7.07M |
| Operating income | -$14.14M | -$14.73M |
| Pretax income | -$14.42M | -$13.85M |
| Income tax | $4,000 | $2,000 |
| Net income | -$14.43M | -$13.85M |
| EBITDA | -$13.24M | -$13.77M |
| EPS (basic) | -8.49 | -8.32 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $8.39M | $3.10M |
| Short-term investments | $2.95M | $15.11M |
| Receivables | $124,000 | $485,000 |
| Current assets | $15.93M | $21.98M |
| PP&E, net | $2.38M | $2.40M |
| Intangibles | $50,000 | $48,000 |
| Total assets | $20.51M | $26.99M |
| Current liabilities | $2.26M | $2.45M |
| Total liabilities | $4.33M | $4.89M |
| Shareholders' equity | $16.17M | $22.10M |
| Shares outstanding | 2.00M | 1.76M |
| Cash flow statement | ||
| Operating cash flow | -$13.45M | -$12.95M |
| Capital expenditure | $879,000 | $833,000 |
| Free cash flow | -$14.33M | -$13.79M |
| Investing cash flow | $11.82M | $5.79M |
| Financing cash flow | $6.92M | -$185,000 |
| Depreciation & amortization | $896,000 | $962,000 |
| Stock-based compensation | $921,000 | $830,000 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.